Fatigue as a symptom of neurological diseases

Cover Page

Cite item

Full Text

Abstract

Objective. The aim of the work was to study the fatigue syndrome in various organic brain diseases.

Materials and methods. Patients in the recovery period of hemispheric stroke, with Parkinson's disease and multiple sclerosis were examined. Along with the clinical one, there was conducted a study using the asthenia questionnaire MFI-20, FIS (Fatigue Impact Scale), FSS (Fatigue Severity Scale).

Results. It has been established that patients with various diseases of the central nervous system have a syndrome of fatigue, which is a nosogenic one, that is, a consequence of organic brain damage.

About the authors

T. V. Baidina

E.A. Vagner Perm State Medical University

Author for correspondence.
Email: tatiana_baidina@mail.ru

MD, PhD, Professor, Department of Neurology and Medical Genetics

Russian Federation, Perm

T. I. Kolesova

LLC “Clinic Medgarant”

Email: tatiana_baidina@mail.ru

Candidate of Medical Sciences, neurologist

Russian Federation, Perm

Yu. V. Malinina

Perm Regional Clinical Hospital

Email: tatiana_baidina@mail.ru

Candidate of Medical Sciences, neurologist

Russian Federation, Perm

T. N. Trushnikova

E.A. Vagner Perm State Medical University

Email: tatiana_baidina@mail.ru

Candidate of Medical Sciences, Assistant, Department of Neurology and Medical Genetics

Russian Federation, Perm

M. A. Danilova

E.A. Vagner Perm State Medical University

Email: tatiana_baidina@mail.ru

Candidate of Medical Sciences, Assistant Professor, Department of Neurology and Medical Genetics

Russian Federation, Perm

References

  1. Nodel' M.R. Fatigue in Parkinson's disease. Zhurnal nevrologii i psihiatrii imeni S.S. Korsakova 2009; 9: 23–26 (in Russian).
  2. Lou J.S. Kearns G., Oken V. et al. Exacerbated physical and mental fatigue in Parkinsons disease. Mov Dis 2001;16: 190–196.
  3. Chaudhuri A., Behan P.O. Fatigue in neurological disorders. The Lan-cet 2004; 363: 978–986.
  4. Bajdina T.V. Inflammatory mechanisms of atherosclerotic lesions of the main arteries of the head in the development of atherothrombotic stroke and the possibility of their therapeutic correction with statins: avtoref. dis. … d-ra med. nauk. Perm' 2006 (in Russian).
  5. Levin O.S., Fedorova N.V., SHtok V.N. Differential diagnosis of parkinsonism. Zhurnal nevrologii i psihiatrii imeni S.S. Korsakova 2003; 3: 54–60 (in Russian).
  6. Chaudhuri A., Behan P.O. Fatigue and basal ganglia. J Neurol Sci 2000; 179: 34–42.
  7. Mendonça D.A., Menezes K, Jog M.S. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial. Movement Disorders 2007; 22 (14): 2070–2076.
  8. Akinceva YU.V., Bajdina T.V. Platelet serotonin in patients with multiple sclerosis. Vrachaspirant 2011; 4 (5.4): 614–619 (in Russian).
  9. Bajdina T.V., Torgan T.I., Demchuk N.D., Danilova M.A. Inflammatory mechanisms of fatigue syndrome formation in Parkinson's disease. Zhurnal nevrologii i psihiatrii im. C.C. Korsakova 2015; 115(3): 61–64 (in Russian).

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Baidina T.V., Kolesova T.I., Malinina Y.V., Trushnikova T.N., Danilova M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).